As advocates and critics debate the FDA’s approval of the new drug, and a chorus of experts and patient advocates protest the price, many patients and their families are excited about it, hopeful that it will stop the debilitating disease…
A consumer advocacy group is calling for the removal of three top FDA officials, saying the agency’s approval of the Alzheimer’s drug aducanumab (Aduhelm) was “reckless.” Source: NEW FEED
As the first Alzheimer’s drug approved since 2003, advocates applaud the decision. Critics say the approval was based on inadequate proof that the drug works and balk at the price tag of $56,000 a year. Source: NEW FEED
There are ways to find quality treatment centers for alcohol or drug addiction. Here’s how to get started. Source: NEW FEED
If you’ve battled a drug or alcohol addiction, you may be nervous about taking medications that treat pain, such as opioids. Learn more about the options you might have and how to weigh them. Source: NEW FEED
An experimental drug appeared to slow cognitive decline in people with early Alzheimer’s disease, according to newly published research. Source: NEW FEED
Many older adults with dementia are prescribed dangerous combinations of drugs that raise their risk of overdose, falls and further mental deterioration, a new study finds. Source: NEW FEED
Older men whose blood pressure rises at night may be at increased risk for Alzheimer’s disease, a new study suggests. Source: NEW FEED
As Tony Bennett releases what may well be his last album, his family has disclosed that the 1950s crooner who became popular with younger audiences decades later has Alzheimer’s disease. Source: NEW FEED
All Alzheimer’s disease patients and their family caregivers should be vaccinated against COVID-19, the Alzheimer’s Foundation of America says. Source: NEW FEED
The AI everyone’s talking about identified Alzheimer’s 80% of the time by analyzing people’s speech. Source: NEW FEED
A new, small study suggests six minutes of high-intensity exercise might prolong the lifespan of a healthy brain, perhaps delaying the start of Alzheimer’s and Parkinson’s diseases. Source: NEW FEED
It’s not a cure, but the drug, given intravenously every 2 weeks, has shown moderate positive effects in clinical trials in slowing early-stage disease. Source: NEW FEED
Living in an area with easy access to parks and rivers appears to slow the progression of devastating neurological diseases, such as Alzheimer’s and Parkinson’s. Source: NEW FEED
A gene on the X chromosome may explain why two-thirds of Alzheimer’s patients are women. Researchers found the gene can be safely inhibited in mice. Are humans next? Source: NEW FEED
Learning more about this gene may lead to future treatments. Source: NEW FEED
Those who enroll are assigned to groups that meet virtually twice a week for 1-hour sessions. The sessions are livestreamed, so participants are engaging with each other and with the instructors in real time. Source: NEW FEED
Early research suggests a type of RA drug known as TNF inhibitors may lower dementia risk in people who have RA and heart disease. Source: NEW FEED
Federal officials have made their final decision: Medicare will only pay for patients to get the new Alzheimer’s drug aducanumab (Aduhelm) if the patients are participating in clinical trials. Source: NEW FEED
How vision rehabilitation services help people with low vision navigate the world. Source: NEW FEED